Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;27(10):1048-1057.
doi: 10.1017/S1355617721000059. Epub 2021 Feb 10.

Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study

Affiliations

Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study

Matthew T Mefford et al. J Int Neuropsychol Soc. 2021 Nov.

Abstract

Objectives: It is uncertain if long-term levels of low-density lipoprotein-cholesterol (LDL-C) affect cognition in middle age. We examined the association of LDL-C levels over 25 years with cognitive function in a prospective cohort of black and white US adults.

Methods: Lipids were measured at baseline (1985-1986; age: 18-30 years) and at serial examinations conducted over 25 years. Time-averaged cumulative LDL-C was calculated using the area under the curve for 3,328 participants with ≥3 LDL-C measurements and a cognitive function assessment. Cognitive function was assessed at the Year 25 examination with the Digit Symbol Substitution Test [DSST], Rey Auditory Visual Learning Test [RAVLT], and Stroop Test. A brain magnetic resonance imaging (MRI) sub-study (N = 707) was also completed at Year 25 to assess abnormal white matter tissue volume (AWMV) and gray matter cerebral blood flow volume (GM-CBFV) as secondary outcomes.

Results: There were 15.6%, 32.9%, 28.9%, and 22.6% participants with time-averaged cumulative LDL-C <100 mg/dL, 101-129 mg/dL, 130-159 mg/dL, and ≥160 mg/dL, respectively. Standardized differences in all cognitive function test scores ranged from 0.16 SD lower to 0.09 SD higher across time-averaged LDL-C categories in comparison to those with LDL-C < 100 mg/dL. After covariate adjustment, participants with higher versus lower time-averaged LDL-C had a lower RAVLT score (p-trend = 0.02) but no differences were present for DSST, Stroop Test, AWMV, or GM-CBFV.

Conclusion: Cumulative LDL-C was associated with small differences in memory, as assessed by RAVLT scores, but not other cognitive or brain MRI measures over 25 years of follow-up.

Keywords: Cholesterol; Cognition; Cohort studies; LDL; Lipids.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: MM and LC report no disclosures. CEL receives research support from grant HHSN26820130026C. PM receives research support from Amgen, Inc. SS and LJL report no disclosures. KLM, AR, and HK are employed by Amgen, Inc. RSR receives research grant support from Akcea, Amgen, Medicines Company and Sanofi; he receives honoraria from Akcea, Kowa, and Pfizer; he has ownership in MediMergent; he receives consultant fees from Akcea, Amgen, Regeneron, and Sanofi; he receives other support from UpToDate. APC receives research support from Amgen, Inc.

References

    1. Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, … HALCyon Study Team. (2014). Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme. Age (Dordr), 36(4), 9673. doi:10.1007/s11357-014-9673-9 - DOI - PMC - PubMed
    1. Appelman AP, van der Graaf Y, Vincken KL, Mali WP, & Geerlings MI (2010). Combined effect of cerebral hypoperfusion and white matter lesions on executive functioning - The SMART-MR study. Dement Geriatr Cogn Disord, 29(3), 240–247. doi:10.1159/000289813 - DOI - PubMed
    1. Benn M, Nordestgaard BG, Frikke-Schmidt R, & Tybjaerg-Hansen A (2017). Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study. BMJ, 357, j1648. doi:10.1136/bmj.j1648 - DOI - PMC - PubMed
    1. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, … Danesh J (2007). Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA, 298(11), 1300–1311. doi:10.1001/jama.298.11.1300 - DOI - PubMed
    1. Bjorkhem I, Cedazo-Minguez A, Leoni V, & Meaney S (2009). Oxysterols and neurodegenerative diseases. Mol Aspects Med, 30(3), 171–179. doi:10.1016/j.mam.2009.02.001 - DOI - PubMed

Publication types

Substances